lexaria bioscienc corp cse lxx otcqx lxrp landmark partnership tobacco titan
market data februari
see back report rate risk definit
figur us unless otherwis specifi
revenu quarter end novemb
reflect yoy declin
revis forecast
million million million
net loss increas million ep
versu net loss million ep
revis net earn forecast million
ep million ep
net earn forecast million ep
compani enter landmark invest partnership
altria group inc nyse mo provis allow
outright purchas lexaria nicotin subsidiari altria
compani construct laboratori
submit applic use cannabinoid
control substanc test activ
lexaria also announc result vivo nicotin
test carri august
maintain fair valu estim per share
fundament research corp year bring undiscov invest opportun forefront www researchfrc com
januari lexaria announc enter definit invest
agreement altria group inc altria tobacco giant produc icon
cigarett brand marlboro lexaria nicotine-focus subsidiari lexaria nicotin
llc lexaria nicotin altra ventur inc altria ventur wholly-own
subsidiari altria enter milestone-bas fund agreement parti
pursu relat develop oral nicotin solut
altria provid initi fund million undisclos minor interest
lexaria nicotin option invest addit fund million
multipl privat placement lexaria nicotin altria also option
acquir lexaria nicotin valuat commensur fair market valu lexaria
nicotin time altria choos exercis option current
enough inform provid valuat lexaria nicotin manag
disclos addit inform us note lexaria sold equiti parent
compani allow lexaria retain ownership dehydratechtm drug deliveri
technolog howev altria grant licens use dehydratechtm oral
nicotin deliveri form exclus basi non-exclus basi
intern per term agreement altria pay lexaria nicotin royalti
revenu gener sale dehydratechtm enabl product time
altria choos exercis right acquir lexaria nicotin entireti
news moment compani major backer potenti
acquiror lexaria nicotin nicotine-focus market also took
news well share lexaria surg high per share day
open per share sinc initi coverag compani
emphas dehydratechtm potenti nicotin space lexaria potenti
acquisit target interest facet transact lexaria retain
control patent technolog even case altria buy lexaria
nicotin substanti better outcom expect allow compani
also pursu technolog potenti nsaid vitamin cannabi space
anticip investor scrutin lexaria nicotin test result ever
success result like result accret subsidiari sale neg
result impli weaker outlook previous forecast
novemb compani announc submit canada
research applic intent oper kelowna -base research
develop laboratori work cannabinoid laboratori
expect enhanc compani abil formul new product may contain
cannabinoid control substanc addit cannabinoid-bas formul
compani expect begin addit experiment work nicotin formul
nsaid vitamin bioactiv compound lab complet compani
previous outsourc lab analysi formul third parti establish
company-own laboratori expect increas work capac whilst reduc cost
develop timelin undisclos portion note altria-fund nicotin
 project expect carri within new kelowna laboratori
altria
fundament research corp year bring undiscov invest opportun forefront www researchfrc com
novemb compani announc launch water-solubl
ready-mix hemp supplement powder packet formul name chrgd
chrgd design ad drink locat
compani
dehydratechtm technolog held two-gram pouch carri around
discreetli also nearli flavorless odorless minim impact tast
beverag chrgd ad compani engag cultiv well inc
california-bas brand develop distribut compani creat distribut
chrgd brand believ chrgd may gener increas product sale
compani histor weak product sale given expect popular
august compani announc result recent complet
anim vivo studi explor applic dehydratechtm deliv nicotin
blood plasma result studi conduct rat follow result
releas august report previou updat report recent studi
found dehydratechtm achiev greater deliveri nicotin anim
subject mark studi control group significantli greater
absorpt level control subsequ time point addit compani
announc august press releas
lexaria technolog deliv nicotin across blood-brain-barri
control formul may allow futur micro dose accord
 food drug administr polici
lexaria formul four time faster reach peak level brain tissu
control formul
announc success result studi posit develop
compani whose technolog could prove signific disruptor
applic activ pharmaceut ingredi api nicotin nsaid
vitamin anticip anim test ensu prior human test
result
fundament research corp year bring undiscov invest opportun forefront www researchfrc com
compani report revenu reflect yoy revenu declin
reason declin signific declin sale compani
proprietari line product partial off-set licens revenu accord
compani lexaria five license cover previou updat report
howev accord manag two canada base yet begun
gener revenu canadian edibl legisl expect pass law
later two other -base startup yet initi meaning
oper follow tabl outlin compani oper perform well
us ye aug
compani larg kept line revenu forecast slightli
miss million revenu project actual revenu million
revenu
fundament research corp year bring undiscov invest opportun forefront www researchfrc com
miss howev base perform revenu
guidanc million may difficult compani achiev revis
revenu forecast million million million
million respect larg maintain long-term
revenu forecast minor reduct short-term reflect slower licens roll-
previous expect lexaria need either sign new licens agreement
gener meaning revenu new product launch ramp sale
exist license meet revenu forecast
gross margin increas compar
signific increas gross margin attribut higher revenu
licens agreement exhibit exceedingli high gross margin
ebitda drop million versu million
furthermor oper cost grew yoy million largest contributor
consult fee promot fee
net loss million ep versu million ep
revis earn forecast million ep
million ep million ep
million ep
lexaria free cash flow first three month declin
million million
summari flow
effect exchang rate
free flow firm
end compani cash posit million work
capit million well current ratio furthermor compani
remain debt-fre strong liquid solvenc posit compani
import maintain lexaria rolls-out busi plan given accumul
license slower previous expect
fundament research corp year bring undiscov invest opportun forefront www researchfrc com
us ye aug
stock option warrant estim compani million stock option
weight averag exercis price million warrant weight averag
exercis price outstand million option million warrant
current in-the-money compani potenti rais million
in-the-money option warrant exercis
updat dcf valuat lexaria share per share versu previou fair
valu per share per share maintain buy rate compani
fair valu estim lexaria share per share
believ compani expos follow risk list non-exhaust
possibl inabl appli lexaria deliveri technolog
propos market segment target materi impact compani valuat
lexaria exist patent guarante intern protect
technology- patent relev author need protect
compani technolog jurisdict
cannabi regulatori environ north america exhibit high level
uncertainti open extern interfer beyond lexaria control advers
polit regulatori chang may materi impact compani valuat
compani yet exhibit track record profit despit oper
access capit share dilut
maintain coverag risk rate specul
fundament research corp year bring undiscov invest opportun forefront www researchfrc com
us ye aug
fundament research corp year bring undiscov invest opportun forefront www researchfrc com
